Cognitive functions in patients with diabetes mellitus;Funkcje poznawcze u chorych na cukrzycȩ

Diabetologia Doswiadczalna i Kliniczna

Volumn 5, Issue 2, 2005, Pages 93-96

  Pierzchała, Krystyna ^a   Kozub Doros, Ilona ^a  

^a Klinika Neurologii Śla̧ska Akademia Medyczna ^*  (Poland)

Author keywords

Cognitive functions; Diabetes mellitus

Indexed keywords

APOLIPOPROTEIN E; CARBOHYDRATE; INSULIN;

ALZHEIMER DISEASE; CARBOHYDRATE METABOLISM; CHRONIC DISEASE; COGNITION; COGNITIVE DEFECT; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; FRONTAL LOBE; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN DEFICIENCY; INTELLECTUAL IMPAIRMENT; LIFE EXPECTANCY; METABOLIC DISORDER; METHODOLOGY; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PSYCHOMETRY; PSYCHOMOTOR PERFORMANCE; PUBLICATION; QUALITY OF LIFE; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VERBAL MEMORY;

EID: 19544376159     PISSN: 16433165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Miles W.R., Root H.F. Psychologic tests applied to diabetic patients. Arch. Intern. Med. 1922; 30: 767-777.
2. Bale R.N. Brain damage in diabetes mellitus. Br. J. Psychiatry 1973; 122: 337-341.
3. Wredling R., Levander S., Adamson U., Lins P.E. Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in men. Diabetologia 1990; 33: 152-157.
4. Langan S.J., Deary I.J., Hepburn D.A., Frier B.M. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 1991; 34: 337-344.
5. Deary I.J., Crawford J.R., Hepburn D.A., Langan S.J., Blackmore L.M., Frier B.M. Severe hypoglycaemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 1993; 42: 341-344.
6. Lincoln N.B., Faliero R.M., Kelly C., Kirk B.A., Jeffcoate W.J. Effect of long-term glycemic control on cognitive function. Diabetes Care 1996; 19: 656-658.
7. McCrimmon R.J., Deary I.J., Frier B.M. Auditory information processing during acute insulin-induced hypoglycaemia in non-diabetic human subjects. Neuropsychologia 1997; 35: 1547-1553.
8. Strachan M.W.J., Deary I.J., Ewing F.M.E., Frier B.M. Recovery of cognitive function and mood after severe hypoglycaemia in adults with insulin-treated diabetes. Diabetes Care 2000; 23: 305-311.
9. Pozzessere G., Yalle E., de Crignis S. i wsp. Abnormalities of cognitive functions in IDDM revealed by P-300 event-related potential analysis. Comparison with short-latency evoked potentials and psychometric tests. Diabetes 1991; 40: 952-958.
10. Kurity-Kurita A., Mochio S., Isogai Y. Changes in auditory P300 event related potentials in diabetes mellitus. Acta Neurol. Scand. 1995; 92: 319-323.
11. Ott A., Stolk R.P., Hofman A., van Harskamp F., Grobbee D.E., Breteler M.M.B. Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 1996; 39: 1392-1397.
12. Dickson D.W., Sinicropi S., Yen S.H. i wsp. Glycation and microglial reaction in lesions of Alzheimer's disease. Neurobiol. Aging 1996; 17: 733-743.
13. Horie K., Miyata T., Takeda A. i wsp. Immunohistochemical localisation of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem. Biophys. Commun. 1997; 236: 327-332.
14. Takeda A., Yasuda T., Miyata T. i wsp. Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain. Neurosci. Lett. 1996; 221: 17-20.
15. Finch C.E., Cohen D.M. Aging, metabolism and Alzheimer's disease: Review and hypotheses. Exp. Neurol. 1997; 143: 82-102.
16. Kalmijn S., Feskens E.J.M., Launer L.J., Kromhout D. Cerebrovascular disease, the apolipoprotein e 4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996; 27: 2230-2235.
17. Strachan M.W.J., Deary I.J., Ewing F.M.E., Frier B.M. Is type II diabetes associated with an increased risk of cognitive dysfunction? Diabetes Care 1997; 20; 438-445.
18. Cooper G.J.S., Willis A.C., Clark A., Turner R.C., Sim R.B., Reid K. B. Purification and characterisation of a peptide from amyloi-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 1987; 84: 8628-8632.
19. Dore S., Kar S., Quirion R. Insulin-like growth factor I protects and rescues hippocampal neurons against B-amyloid and human amylin-induced toxicity. Proc. Natl. Acad. Sci. USA 1997; 94: 4772-4777.
20. Edgington S.M. Amyloid plaque and diabetes. New research suggests Alzheimer's disease and type II diabetes share a similar pathology. Bio. Technol. 1994; 12: 591-594.